期刊文献+

新西兰兔对SARS-CoV实验灭活疫苗的体液免疫应答

Humoral immune responses in rabbits with an experimental SARS-CoV inactivated vaccine
下载PDF
导出
摘要 目的:评价SARS-CoV广东F69分离株实验灭活疫苗的免疫效果。方法:病毒悬液经0·4%甲醛灭活后作为抗原,对新西兰兔进行免疫接种;采用ELISA法和微量细胞中和试验,检测血清特异性IgG抗体和中和抗体的消长规律。结果:初次免疫后第3天,即能检测到抗SARS-CoV特异性抗体,第7天检测到中和抗体。二次免疫后,特异性IgG抗体和中和抗体效价于第6周左右分别达到1∶81920和1∶20480的峰值水平。继续加强免疫,特异性抗体水平无明显变化。F69分离株与Z2-Y3广东分离株之间能够完全交叉中和。结论:F69毒株实验灭活疫苗具有很强的免疫原性。F69与Z2-Y3毒株之间尽管存在基因序列差异,但能够完全交叉免疫保护。 Objective:To evaluate the immunogenicity of an experimental SARS-CoV inactivated vaccine. Methods:The virus suspension of F69 strain was inactivated with 0. 4% formaldehyde and purified,then used as the immune antigen combined with Freund' s adjuvant. Eight adult New Zealand rabbits were immunized 4 times with this vaccine. 12 sets of rabbit serum were sampled from the third day to 74th day after first immunization. Titers of specific IgG antibody and neutralizing antibody were determined by indirect ELISA and micro-cytopathic effect neutralizing test. Results:Rapid and potent humorsl immune responses were induced by F69 inactivated vaccine in all eight immunized rabbits. Both specific IgG antibody and neutralizing antibody all peaked just with 2 vaccinations, with the maximum titer of 1: 81 920 and 1: 20 480 respectively about 6 weeks after first immunization. Across neutralizing reaction existed between F69 and Z2-Y3 strains. Conclusion:F69 inactivated vaccine owns strong immunogenicity. Similar antigenic epitopes exist between the F69 strain and Z2-Y3 strain ,which ensured the cross neutralizing reaction.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第5期420-421,共2页 Chinese Journal of Immunology
基金 广东省非典科技攻关专项(2003Z3-E0461)资助
关键词 SARS-COV 灭活疫苗 免疫原性 中和抗体 SARS coronavirus Inactivated vaccine Immunogenicity Neutralizing antibody
  • 相关文献

参考文献6

  • 1张传海,王一飞,张美英,戚树源.SARS及其病原体研究进展[J].生命科学,2003,15(3):129-133. 被引量:7
  • 2Marra M A,Jones S J,Astell CR et al.The genome sequence of the SARS-associated coronavirus[J].Science,2003; 300 (5624):1399-1404.
  • 3鄢心革,万卓越,张欣,陈秋霞,郑夔,黄吉城,黄平,陆家海.广东省严重急性呼吸综合征病毒的分离和鉴定[J].中华实验和临床病毒学杂志,2003,17(3):213-216. 被引量:2
  • 4陆家海 鄢新革 郭中敏etal.SARS病毒的分离、鉴定和疫苗毒株(F69)的确定[J].广东医学,2003,24(Ⅱ):194-195.
  • 5WHO,1997.Manual for the virological investigation of polio[M].WHO/EPI/GEN/97.01
  • 6The Chinese SAR S Molecular Epidemiology Consortium.Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China[J].Science,2004 ;303 (5664):1666-1669.

二级参考文献15

  • 1Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003. Morb Mort Wkly Rep[R].2003; 52(12): 241-248.
  • 2American CDCP. Preliminary clinical description of severe acute respiratory syndrome. Morb Mortal Wkly Rep[R]. 2003; 52: 255--256.
  • 3Tsang K W, Ho P L, Ooi G C, et al. h cluster of casesof severe acute respiratory syndrome in Hong Kong.N Engl J Med, 2003; 348(20): 1977--1985.
  • 4Poutanen S M, Low D E, Henry B, et al. Identification of severe acute respiratory syndrome in Canada.N Enql J Med, 2003; 348(20): 1995--2005.
  • 5Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Enyl J Med, 2003; 348(20): 1986--1994.
  • 6Peiris J S, Lai S T, Poon L L, et al. Coronavirus as a possible cause of severe acute respiratory syndrome.Lancet, 2003; 361(9366): 1319--1325.
  • 7Ksiazek T GI Erdman D, Goldsmith C, et al, A novel coronavirus associated with severe acute respiratory syndrome. N Enyl J Med, 2003; 348(20): 1953--1966.
  • 8Drosten C, Gunther S, Preiser W, et al, Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Enyl J Med, 2003; 348(20):1967--1976.
  • 9Greensili J, McNamara P S, Dove W, et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis, 2003; 9(3): 372--375.
  • 10Cameron PA, Rainer TH. Update on emerging infections: news from the Centers for Disease Control and Prevention. Update: Outbreak of severe acute respiratory syndrome--worldwide. Ann Emerg Med, 2003,42 : 110-112.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部